Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

Clinical studies indicate that the mRNA vaccine may help treat pancreatic cancer, one of the deadliest cancers, reports ...

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

As few as one in ten people survive pancreatic cancer five years after their diagnosis — making it the most difficult cancer to survive. The survival rate five years after diagnosis is 6-14%, but ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...

Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, ...

Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...

Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra ...

One particular challenge in the treatment of cancer is therapy resistance. An international research team has now discovered a mechanism that opens up new treatment strategies for tumors in which ...

Ribonucleic acid, commonly known as RNA, is involved in many biological functions, and some, including gene silencing, are utilized to cure diseases. RNA has recently gained attention as a promising ...